Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells

Biochemical Pharmacology

Volumn 55, Issue 1, 1998, Pages 53-64

  Qiao, Liang ^a,c   Hanif, Rashid ^a   Sphicas, Eleana ^b   Shiff, Steven J ^a,b   Rigas, Basil ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

Apoptosis; Aspirin; Chemoprevention; DNA strand breaks; NSAIDs

Indexed keywords

ACETYLSALICYLIC ACID;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE RESPONSE; ELECTROPHORESIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; CELL DIVISION; CELL SURVIVAL; DNA DAMAGE; DNA, NEOPLASM; FLOW CYTOMETRY; HT29 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; MICROTOMY;

EID: 0031911922     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00400-0     Document Type: Article

References (35)

1. 1. Thun MJ, NSAID use and decreased risk of gastrointestinal cancers. Gastroenterol Clin N Am 25: 333-348, 1996.
2. 2. Reddy B, Rao C, Rivenson A and Kelloff G, Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493-1497, 1993.
3. 3. Pollard M and Luckert PH, Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 214: 558-559, 1981.
4. 4. Waddell WR and Loughry RW, Sulindac for polyposis of the colon. J Surg Oncol 24: 83-87, 1983.
5. 5. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR and Offerhaus GJ, Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl J Med 328: 1313-1316, 1993.
6. 6. Marnett LJ, Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575-5589, 1992.
7. 7. Vane JR, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232-235, 1971.
8. 8. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SJ and Rigas B, Effect of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52: 237-245, 1996.
9. 9. Shiff SJ, Qiao L, Tsai L-L and Rigas B, Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J Clin Invest 96: 491-503, 1995.
10. 10. Shiff SJ, Koutsos MI, Qiao L and Rigas B, Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: Effects on cell cycle and apoptosis. Exp Cell Res 222: 179-188, 1996.
11. 11. Kerr JFR, Wyllie AH and Currie AR, Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
12. 12. Wyllie AH, Kerr JFR and Currie AR, Cell death: The significance of apoptosis. Int Ren Cytol 68: 251-306, 1980.
13. 13. Duvall E and Wyllie AH, Death and the cell. Immunol Today 7: 115-118, 1986.
14. 14. Gavrieli Y, Sherman Y and Ben-Sasson SA, Identification of programmed cell death m situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
15. 15. Kerr JFR and Harmon BV, Definition and incidence of apoptosis: An historical perspective. In: Apoptosis: The Molecular Biology of Cell Death (Eds. Tomei LD and Cope FO), pp. 5-30. Cold Spring Harbor Laboratory Press, Plainview, NY, 1991.
16. 16. Columbano A, Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58: 181-190, 1995.
17. 17. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Toyka KV and Lassmann H, Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 71: 219-225, 1994.
18. 18. Gorczyca W, Gong J and Darsynkiewicz Z, Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951, 1993.
19. 19. Li X, Traganos F, Melamed MR and Darzynkiewicz Z, Single-step procedure for labeling DNA strand breaks with fluorescein-or BODIPY-conjugated deoxynucleotides: Detection of apoptosis and bromodeoxyuridine incorporation. Cytometry 20: 172-180, 1995.
20. 20. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H and Wick G, Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 10: 41-42, 1994.
21. 21. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, Lassota P and Traganos F, Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808, 1992.
22. 22. Cohen JJ, Apoptosis. Immunol Today 14: 126-130, 1993.
23. 23. Singh NP, McCoy MT, Tice RR and Schneider EL, A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 175: 184-191, 1988.
24. 24. Gedik CM, Ewen SWB and Collins AR, Single cell gel electrophoresis applied to the analysis of UV-C damage and its repair in human cells. Int J Radiat Biol 62: 313-320, 1992.
25. 25. Olive PL, Frazer G and Banath JP, Radiation-induced apoptosis measured in TK6 human B lymphoblast cells using the comet assay. Radiat Res 136: 130-136, 1993.
26. 26. Collins RJ, Harmon BV, Gobé GC and Kerr JFR, Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 61: 451-453, 1992.
27. 27. Goldberg Y, Nassif II, Pittas A, Tsai L-L, Dynlacht BD, Rigas B and Shiff SJ, The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: Alterations in tumor suppressor and celi cycle-regulatory proteins. Oncogene 12: 893-901, 1996.
28. 28. Bortner CD, Oldenburg NBE and Cidlowski JA, The role of DNA fragmentation in apoptosis. Trends Cell Biol 5: 21-26, 1995.
29. 29. Farber E, Programmed cell death: Necrosis versus apoptosis. Mod Pathol 7: 605-609, 1994.
30. 30. Inoue M, Morikawa M, Tsuboi M, Ito Y and Sugiura M, Comparative study of human intestinal and hepatic esterases as related to enzymatic properties and hydrolyzing activity for ester-type drugs. Jpn J Pharmacol 30: 529-535, 1980.
31. 31. Kopp E and Ghosh S, Inhibition of NF-κB by sodium salicylate and aspirin. Science 265: 956-958, 1994.
32. 32. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML, Piantadosi S, Hamilton SR and Giardiello FM, The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 109: 994-998, 1995.
33. 33. Nugent KP, Farmer KC, Spigelman AD, Williams CB and Phillips RK, Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 80: 1618-1619, 1993.
34. 34. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR and Jones RJ, Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55: 1811-1816, 1995.
35. 35. Strater J, Koretz K, Gunthert AR and Moller P, In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut 37: 819-825, 1995.